本部落公告
因家母年輕就罹患晚期乳癌，故這幾年來收集了許多期刊，摘要翻譯在自己的網頁上，也發行了一份電子報。為了讓更多人能分享這類資訊，才決定弄個blog。雖然階段性任務完成以後可能就會停掉，但不管如何，還是希望有人能從中受益。2008/01/03
2007/08/03
用letrozole與Herceptin作為HER2陽性與雌激素受體陽性的晚期乳癌病人之第一線或第二
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancersP. Kelly Marcom, Claudine Isaacs, Lyndsay Harris, Zee Wang Wong, Aruna Kommarreddy, Nellie Novielli, Gretchen Mann, Yu Tao and Matthew J. Ellis
Breast Cancer Research and Treatment Volume 102, Number 1 / March, 2007 Pages 4
3-49
繼續閱讀
2007/08/03
Vinflunine：晚期乳癌之新的第二線治療藥物
Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
British Journal of Cancer (2006) 95, 1161-1166.
繼續閱讀
2007/08/03
在經過多種治療的轉移乳癌病人併用健澤與oxaliplatin
Gemcitabine–Oxaliplatin Combination in Heavily Pretreated Metastatic Breast Cancer: A Pilot Study on 43 PatientsThe Breast Journal
Volume 13 Issue 2 Page 165-171, March/April 2007
繼續閱讀
2007/08/03
Capecitabine (截瘤達（Xeloda))
The Oncologist, Vol. 12, No. 2, 152-155, February 2007;
doi:10.1634/theoncologist.12-2-152
Schellens, J. H.M.
繼續閱讀
2007/06/30
以15分或60分之時間經靜脈注射ibandronate對於腎臟的安全性
[1078] Renal safety of intravenous ibandronate 6mg infused over 15 or 60 minutesin patients with breast cancer and bone metastases.
繼續閱讀
2007/06/30
不管先前是否接受過雙磷酸鹽類藥物治療，ibandronate都可以減低病人的疼痛
[1076] Pain reduction with ibandronate is achieved regardless of prior bisphosphonate treatment.
繼續閱讀
2007/06/30
併用Avastin以及與白蛋白結合之紫杉醇（Abraxane）治療轉移乳癌病人
[1095] Bevacizumab (avastin) and albumin bound paclitaxel (abraxane) treatment in metastatic breast cancer.
繼續閱讀
2007/06/30
併用Iressa與docetaxel治療轉移乳癌病人
[1093] A randomized phase II trial with gefitinib and docetaxel in metastatic breast cancer: an evaluation of the treatment regimen and the factors associated w
ith toxicity.
繼續閱讀
2007/06/23
Lapatinib治療晚期或轉移乳癌病人的第二期試驗
SABCS[1091] Phase II clinical study of lapatinib (GW572016) in patients with advanced
or metastatic breast cancer.
繼續閱讀
